NK Cell Therapy Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global NK Cell Therapy market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global NK Cell Therapy market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global NK Cell Therapy market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global NK Cell Therapy market segmented into
- NK Cell Therapies
- NK Cell Directed Antibodies
- NK Cell Therapy Breakdown Data by Application
- Cancer
- Gastrointestinal Diseases
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Fate Therapeutics
- Glycostem Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- NantWorks
- Nkarta Therapeutics
- Fortress Biotech
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NK CELL THERAPY INDUSTRY
2.1 Summary about NK Cell Therapy Industry
2.2 NK Cell Therapy Market Trends
2.2.1 NK Cell Therapy Production & Consumption Trends
2.2.2 NK Cell Therapy Demand Structure Trends
2.3 NK Cell Therapy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 NK Cell Therapies
4.2.2 NK Cell Directed Antibodies
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 NK Cell Therapy Breakdown Data by Application
4.3.2 Cancer
4.3.3 Gastrointestinal Diseases
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 NK Cell Therapies
5.2.2 NK Cell Directed Antibodies
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 NK Cell Therapy Breakdown Data by Application
5.3.2 Cancer
5.3.3 Gastrointestinal Diseases
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 NK Cell Therapies
6.2.2 NK Cell Directed Antibodies
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 NK Cell Therapy Breakdown Data by Application
6.3.2 Cancer
6.3.3 Gastrointestinal Diseases
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 NK Cell Therapies
7.2.2 NK Cell Directed Antibodies
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 NK Cell Therapy Breakdown Data by Application
7.3.2 Cancer
7.3.3 Gastrointestinal Diseases
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 NK Cell Therapies
8.2.2 NK Cell Directed Antibodies
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 NK Cell Therapy Breakdown Data by Application
8.3.2 Cancer
8.3.3 Gastrointestinal Diseases
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 NK Cell Therapies
9.2.2 NK Cell Directed Antibodies
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 NK Cell Therapy Breakdown Data by Application
9.3.2 Cancer
9.3.3 Gastrointestinal Diseases
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Nektar Therapeutics
10.1.2 Innate Pharma SA
10.1.3 Affimed
10.1.4 Chipscreen Biosciences
10.1.5 Fate Therapeutics
10.1.6 Glycostem Therapeutics
10.1.7 Dragonfly Therapeutics
10.1.8 Kiadis Pharma
10.1.9 NantWorks
10.1.10 Nkarta Therapeutics
10.1.11 Fortress Biotech
10.2 NK Cell Therapy Sales Date of Major Players (2017-2020e)
10.2.1 Nektar Therapeutics
10.2.2 Innate Pharma SA
10.2.3 Affimed
10.2.4 Chipscreen Biosciences
10.2.5 Fate Therapeutics
10.2.6 Glycostem Therapeutics
10.2.7 Dragonfly Therapeutics
10.2.8 Kiadis Pharma
10.2.9 NantWorks
10.2.10 Nkarta Therapeutics
10.2.11 Fortress Biotech
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NK CELL THERAPY INDUSTRY
2.1 Summary about NK Cell Therapy Industry
2.2 NK Cell Therapy Market Trends
2.2.1 NK Cell Therapy Production & Consumption Trends
2.2.2 NK Cell Therapy Demand Structure Trends
2.3 NK Cell Therapy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 NK Cell Therapies
4.2.2 NK Cell Directed Antibodies
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 NK Cell Therapy Breakdown Data by Application
4.3.2 Cancer
4.3.3 Gastrointestinal Diseases
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 NK Cell Therapies
5.2.2 NK Cell Directed Antibodies
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 NK Cell Therapy Breakdown Data by Application
5.3.2 Cancer
5.3.3 Gastrointestinal Diseases
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 NK Cell Therapies
6.2.2 NK Cell Directed Antibodies
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 NK Cell Therapy Breakdown Data by Application
6.3.2 Cancer
6.3.3 Gastrointestinal Diseases
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 NK Cell Therapies
7.2.2 NK Cell Directed Antibodies
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 NK Cell Therapy Breakdown Data by Application
7.3.2 Cancer
7.3.3 Gastrointestinal Diseases
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 NK Cell Therapies
8.2.2 NK Cell Directed Antibodies
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 NK Cell Therapy Breakdown Data by Application
8.3.2 Cancer
8.3.3 Gastrointestinal Diseases
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 NK Cell Therapies
9.2.2 NK Cell Directed Antibodies
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 NK Cell Therapy Breakdown Data by Application
9.3.2 Cancer
9.3.3 Gastrointestinal Diseases
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Nektar Therapeutics
10.1.2 Innate Pharma SA
10.1.3 Affimed
10.1.4 Chipscreen Biosciences
10.1.5 Fate Therapeutics
10.1.6 Glycostem Therapeutics
10.1.7 Dragonfly Therapeutics
10.1.8 Kiadis Pharma
10.1.9 NantWorks
10.1.10 Nkarta Therapeutics
10.1.11 Fortress Biotech
10.2 NK Cell Therapy Sales Date of Major Players (2017-2020e)
10.2.1 Nektar Therapeutics
10.2.2 Innate Pharma SA
10.2.3 Affimed
10.2.4 Chipscreen Biosciences
10.2.5 Fate Therapeutics
10.2.6 Glycostem Therapeutics
10.2.7 Dragonfly Therapeutics
10.2.8 Kiadis Pharma
10.2.9 NantWorks
10.2.10 Nkarta Therapeutics
10.2.11 Fortress Biotech
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table NK Cell Therapy Product Type Overview
2.Table NK Cell Therapy Product Type Market Share List
3.Table NK Cell Therapy Product Type of Major Players
4.Table Brief Introduction of Nektar Therapeutics
5.Table Brief Introduction of Innate Pharma SA
6.Table Brief Introduction of Affimed
7.Table Brief Introduction of Chipscreen Biosciences
8.Table Brief Introduction of Fate Therapeutics
9.Table Brief Introduction of Glycostem Therapeutics
10.Table Brief Introduction of Dragonfly Therapeutics
11.Table Brief Introduction of Kiadis Pharma
12.Table Brief Introduction of NantWorks
13.Table Brief Introduction of Nkarta Therapeutics
14.Table Brief Introduction of Fortress Biotech
15.Table Products & Services of Nektar Therapeutics
16.Table Products & Services of Innate Pharma SA
17.Table Products & Services of Affimed
18.Table Products & Services of Chipscreen Biosciences
19.Table Products & Services of Fate Therapeutics
20.Table Products & Services of Glycostem Therapeutics
21.Table Products & Services of Dragonfly Therapeutics
22.Table Products & Services of Kiadis Pharma
23.Table Products & Services of NantWorks
24.Table Products & Services of Nkarta Therapeutics
25.Table Products & Services of Fortress Biotech
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global NK Cell Therapy Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global NK Cell Therapy Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global NK Cell Therapy Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global NK Cell Therapy Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table NK Cell Therapy Product Type Overview
2.Table NK Cell Therapy Product Type Market Share List
3.Table NK Cell Therapy Product Type of Major Players
4.Table Brief Introduction of Nektar Therapeutics
5.Table Brief Introduction of Innate Pharma SA
6.Table Brief Introduction of Affimed
7.Table Brief Introduction of Chipscreen Biosciences
8.Table Brief Introduction of Fate Therapeutics
9.Table Brief Introduction of Glycostem Therapeutics
10.Table Brief Introduction of Dragonfly Therapeutics
11.Table Brief Introduction of Kiadis Pharma
12.Table Brief Introduction of NantWorks
13.Table Brief Introduction of Nkarta Therapeutics
14.Table Brief Introduction of Fortress Biotech
15.Table Products & Services of Nektar Therapeutics
16.Table Products & Services of Innate Pharma SA
17.Table Products & Services of Affimed
18.Table Products & Services of Chipscreen Biosciences
19.Table Products & Services of Fate Therapeutics
20.Table Products & Services of Glycostem Therapeutics
21.Table Products & Services of Dragonfly Therapeutics
22.Table Products & Services of Kiadis Pharma
23.Table Products & Services of NantWorks
24.Table Products & Services of Nkarta Therapeutics
25.Table Products & Services of Fortress Biotech
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global NK Cell Therapy Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global NK Cell Therapy Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global NK Cell Therapy Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global NK Cell Therapy Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global NK Cell Therapy Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global NK Cell Therapy Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global NK Cell Therapy Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global NK Cell Therapy Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global NK Cell Therapy Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global NK Cell Therapy Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global NK Cell Therapy Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure NK Cell Therapy Sales Revenue (Million USD) of Nektar Therapeutics 2017-2020e
72.Figure NK Cell Therapy Sales Revenue (Million USD) of Innate Pharma SA 2017-2020e
73.Figure NK Cell Therapy Sales Rev
1.Figure Global NK Cell Therapy Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global NK Cell Therapy Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global NK Cell Therapy Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global NK Cell Therapy Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global NK Cell Therapy Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global NK Cell Therapy Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global NK Cell Therapy Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure NK Cell Therapies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure NK Cell Directed Antibodies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure NK Cell Therapy Breakdown Data by Application Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Gastrointestinal Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure NK Cell Therapy Sales Revenue (Million USD) of Nektar Therapeutics 2017-2020e
72.Figure NK Cell Therapy Sales Revenue (Million USD) of Innate Pharma SA 2017-2020e
73.Figure NK Cell Therapy Sales Rev
